PERFORMANCE SHARE UNIT AGREEMENT UNDER THE CATALENT, INC. 2018 OMNIBUS INCENTIVE PLAN (Performance Period commencing on July 1, ____ and ending on June 30, ____)Performance Share Unit Agreement • December 8th, 2023 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Pursuant to the Performance Share Unit Grant Notice (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Performance Share Unit Agreement, including, as applicable, any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, along with Exhibit A, this “Agreement”), and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.
OPTION AGREEMENT UNDER THE CATALENT, INC. 2018 OMNIBUS INCENTIVE PLANOption Agreement • December 8th, 2023 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Pursuant to the Option Grant Notice (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Option Agreement, including, as applicable, any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, this “Agreement”), and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.
RESTRICTED STOCK UNIT AGREEMENT UNDER THE CATALENT, INC. 2018 OMNIBUS INCENTIVE PLANRestricted Stock Unit Agreement • December 8th, 2023 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Pursuant to the Restricted Stock Unit Grant Notice (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Restricted Stock Unit Agreement, including, as applicable, any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, this “Agreement”) and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.
RESTRICTED STOCK UNIT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER THE CATALENT, INC.Restricted Stock Unit Agreement • December 8th, 2023 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Pursuant to the Restricted Stock Unit Grant Notice for Non-Employee Directors (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Restricted Stock Unit Agreement for Non-Employee Directors (the “Restricted Stock Unit Agreement”) including, if applicable, any special terms and conditions for the Participant’s country set forth in Appendix A attached hereto (collectively, this “Agreement”), and the Catalent, Inc. 2018 Omnibus Incentive Plan, Catalent, Inc. (the “Company”) and the Participant agree as follows.
EMPLOYMENT AGREEMENTEmployment Agreement • December 8th, 2023 • Catalent, Inc. • Pharmaceutical preparations
Catalent Pharma Solutions GmbH, having its registered office and maintaining a place of business at Riedstrasse 1 in 6330 Cham, Switzerland (the ‘Employer’), lawfully represented by Fréderic Gilot, its Director under the Articles of Association (statutair directeur);
